Revery, First Local Brand To Offer Exosome-based Anti-ageing Solution

KUALA LUMPUR, June 27 (Bernama) -- Revery International Group Berhad (REVERY) has become the first Malaysian brand to offer exosome-based home treatment, known as ReLabo's, which leverages stem cell-derived exosomes with potent skincare components.

REVERY chief executive officer Tiffany Loh said ReLabo's new anti-ageing solution offers a cutting-edge approach by harnessing exosomes from stem cell technology to address initial signs of ageing.

She said the company's analysis shows that the global anti-ageing market is growing and targeted to reach US$61.7 billion (RM291.1 billion) by 2027.

"The demographic seeking anti-ageing solutions is becoming younger, especially among those aged 26 to 35 years old," she said at the launch of the brand’s latest product line, ReLabo, yesterday.

Considering the demand and age-group pattern, Loh said the company had invested over RM5 million in research and development (R&D) to develop anti-ageing solutions.

Meanwhile, REVERY medical director Dr Malcom Lee said the company's ongoing research focuses on developing innovative, effective and accessible skincare solutions, and the company has found that the safest and most effective approaches often involve at-home treatments.

"Advances in skincare technology, particularly those utilising stem cell-derived ingredients, offer professional-level results without invasive procedures. We are confident that ReLabo provides women with the convenience and ensures consistent application for maintaining healthy, youthful skin," he said.

At the event, the company also announced its next venture, a medical healthcare centre focusing on cardiac health evaluations and professional health consultations.

REVERY chief operating officer Nor Ilyana Zainuddin said the proposed healthcare centre at Bandar Rimbayu, Selangor, would be ready by the third quarter of this year.

"We will have multiple specialities in the medical centre, such as cardiologist family medicine, and we would consider adding more along the line," she said.

REVERY is a comprehensive biomedical group integrating R&D, production, sales and service.

-- BERNAMA

Disclaimer: This is a paid advertorial. BERNAMA assumes no responsibility for the content, accuracy and opinions carried in the article.